文献速递腹部泌尿生殖CT

肾上腺碘摄取:双层光谱CT诊断急性脓毒性休克的新型可靠生物标志物

Iodine uptake of adrenal glands: A novel and reliable spectral dual-layer computed tomographic-derived biomarker for acute septic shock.
PubMed 文献 · Eur J Radiol · 2022-09-10

本研究纳入95例接受腹部增强CT的患者,评估双层光谱探测器CT(SDCT)测量的腹部器官碘浓度能否作为脓毒性休克的影像生物标志物。结果显示,脓毒性休克组肾上腺碘浓度显著高于非休克组(4.88±1.16 mg/ml vs 2.67±1.07 mg/ml,p<0.01),其他器官无显著差异。单侧肾上腺碘摄取>3.5 mg/ml或双侧合计>7 mg/ml可识别脓毒性休克患者,敏感度和特异度均较高。

要点

  • 脓毒性休克患者肾上腺碘浓度显著升高,可作为SDCT衍生影像生物标志物。
  • 单侧肾上腺碘摄取>3.5 mg/ml诊断敏感度0.926、特异度0.849、AUC=0.951。
  • 双侧肾上腺合计碘摄取>7 mg/ml诊断敏感度0.889、特异度0.836、AUC=0.928。

关键影像表现/征象

  • 脓毒性休克组肾上腺平均碘浓度和CT值分别为4.88±1.16 mg/ml和153±36 HU,非休克组分别为2.67±1.07 mg/ml和112±41 HU。
  • 脓毒性休克组肾上腺碘浓度显著高于非休克组(p<0.01),其他器官两组间无显著差异。
  • 所有测量器官中碘浓度(mg/ml)与CT值(HU)显著相关,相关系数r从0.809(胰腺)到0.963(右肾)。

诊断标准与关键数值

  • 单侧肾上腺碘摄取>3.5 mg/ml诊断脓毒性休克:敏感度=0.926,特异度=0.849,AUC=0.951。
  • 双侧肾上腺合计碘摄取>7 mg/ml诊断脓毒性休克:敏感度=0.889,特异度=0.836,AUC=0.928。
  • 两名医师测量碘浓度(mg/ml)的组间信度很好(κ=0.8;p<0.01),测量CT值(HU)的组间信度良好(κ=0.773;p<0.01)。

临床应用与阅片要点

  • 在腹部增强SDCT阅片时,可关注肾上腺碘浓度,单侧>3.5 mg/ml或双侧合计>7 mg/ml提示脓毒性休克可能。
  • 测量时需确保为增强扫描,并注意双侧肾上腺的碘浓度测量,避免遗漏单侧或双侧异常。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Septic shock is a potentially fatal condition. This study aims to assess whether iodine uptake and iodine density of abdominal organs on dual-layer spectral detector computed tomography (SDCT) could serve as a new imaging biomarker for patients in septic shock.

METHODS: Here, 95 patients who received contrast-enhanced abdominal CT examinations were included and separated into two groups: group A - septic shock; group B - no shock condition. Preselected abdominal (right and left adrenal gland, right and left kidney, infrarenal inferior vena cava (IVC), pancreas, spleen, and liver) localizations were independently evaluated by two radiologists, who measured iodine concentrations (mg/ml) and Hounsfield units (HU).

RESULTS: In all, 1520 measurements of iodine concentrations in mg/ml and HU were performed, with 27 patients in group A and 68 in group B. Iodine concentrations in mg/ml and HU correlated significantly in all organs measured. The corresponding correlation coefficient (r) ranged from 0.809 (pancreas) to 0.963 (right kidney). Inter-rater reliability (IRR) was very good for mg/ml (κ = 0.8; p < 0.01) and good for HU (κ = 0.773; p < 0.01) measurements. The mean iodine concentration and HU of the adrenal glands in septic and nonseptic patients was 4.88 ± 1.16 mg/ml/153 ± 36 HU and 2.67 ± 1.07 mg/ml/112 ± 41 HU, respectively. Iodine concentrations in the adrenal glands were significantly higher in group A than in group B patients (p < 0.01). The other organs remained unaffected and no significant difference was observed between patients in group A and B. Patients in group A presented significantly more often with an iodine uptake of >3.5 mg/ml of one adrenal gland (sensitivity = 0.926, specificity = 0.849, AUC = 0.951) or/and a combined concentration of >7 mg/ml of both adrenal glands (sensitivity = 0.889, specificity = 0.836, AUC = 0.928).

CONCLUSION: SDCT-derived iodine concentration of the adrenal glands could serve as a novel imaging biomarker for patients in acute septic shock. Our data suggest that an iodine uptake of >3.5 mg/ml of at least one adrenal gland or a combined iodine uptake of >7 mg/ml in both adrenal glands identifies patients in this condition.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Langguth, Aludin, Horr, et al. Iodine uptake of adrenal glands: A novel and reliable spectral dual-layer computed tomographic-derived biomarker for acute septic shock. Eur J Radiol. 2022. PMID: 36108480. doi:10.1016/j.ejrad.2022.110492

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。